Breast Cancer Risk Estimator: Simplified 4-Factor Calculator
This page is a simplified breast cancer risk estimator, not the IBIS / Tyrer-Cuzick clinical model. It multiplies five factor weights (the four original factors plus atypical hyperplasia) against an age-specific average baseline to give a 5-year estimate, an average-risk comparison, a risk band, and an approximate lifetime figure. If you searched for the IBIS calculator, this is not it: the real thing is licensed clinical software, and the section below on how this differs from the real IBIS model points you to the official licensed IBIS tool. The article below shows the exact arithmetic this estimator uses, its limits, and where to get a real clinical assessment.
Quick Answer
This simplified estimator multiplies five weights (menarche age, first-birth age, affected first-degree relatives, previous biopsies, atypical hyperplasia) and applies the product to the published average 5-year risk for your age band. For the pre-filled example (periods at 11-12, first birth at 25-29, one affected relative, one biopsy, no atypical hyperplasia) the combined multiplier is 3.1416, giving a 5-year estimate of 5.72% against a 1.82% average for age 55 (band: High) and an approximate lifetime figure of 33.32%. It is an educational starting point for a conversation with a clinician, not a clinical IBIS assessment.
How to use this breast cancer risk estimator
Fill in all six fields and click Calculate; the tool refuses to run until every field has a value. Five of the fields are dropdowns because each answer maps to a fixed weight, shown in the formula table below, so you can check the arithmetic by hand.
- Patient age. Enter your age from 35 to 85. Age sets the baseline from the published average-risk table: 0.58% at 35, 0.96% at 40, 1.35% at 45, 1.56% at 50, 1.82% at 55, 2.09% at 60, 2.31% at 65, 2.35% at 70, 2.15% at 75, 1.75% at 80 (nearest band used).
- Age at first menstrual period. Pick the band that fits. Earlier bands carry higher weights.
- Age at first live birth. Pick a band, or “No live births” (weight 1.4).
- First-degree relatives with a breast cancer history. Mother, sisters and daughters only: 0, 1, or 2 or more.
- Previous biopsies. 0, 1, or 2 or more, regardless of what the biopsies showed.
- Atypical hyperplasia. Say whether any biopsy showed atypical hyperplasia. Yes multiplies the result by 1.82, the Gail-model factor for this finding; No leaves it unchanged.
Two behaviours are worth knowing before you trust the output. First, changing only the age and recalculating now changes the result, because the baseline rises with age to 70 and then eases. Second, the lifetime figure is no longer five times the 5-year figure: it combines the same age-band averages across each remaining 5-year band to about age 90, treating each band as a separate period, so it is an approximation, not a clinical lifetime figure. A real lifetime risk curve also reflects competing mortality, and the sections below explain what a clinical assessment does instead.
The formula this tool actually uses
The whole calculation fits in three lines. Age now enters through the baseline:
5-year estimate = age-band average × (menarche weight × first-birth weight × family-history weight × biopsy weight × atypia factor)
Approximate lifetime figure = 1 minus the product over each remaining 5-year band of (1 minus band average × combined multiplier), to about age 90
| Factor | Answer | Weight |
|---|---|---|
| Age at first period | Under 11 / 11-12 / 13-14 / 15+ | 1.2 / 1.1 / 1.0 / 0.9 |
| Age at first live birth | Under 20 / 20-24 / 25-29 / 30+ / none | 0.8 / 1.0 / 1.2 / 1.5 / 1.4 |
| First-degree relatives affected | 0 / 1 / 2 or more | 1.0 / 1.7 / 2.6 |
| Previous biopsies | 0 / 1 / 2 or more | 1.0 / 1.4 / 1.7 |
| Atypical hyperplasia | No / Yes | 1.00 / 1.82 |
The weights point the same direction as the evidence summarised by the National Cancer Institute’s breast cancer risk factor review: earlier menarche, later first birth, affected close relatives and previous breast biopsies all raise risk. What this tool leaves out is magnitude and interaction. In validated models these factors are fitted against population incidence data, they interact with each other, and age dominates everything. Here they are simply multiplied together. The 5-year range now depends on age: at age 55 it runs from 1.31% (0.72 × 1.82%) to 14.48% (7.956 × 1.82%) before atypia, and atypia lifts the top to 26.35% (14.48% × 1.82).
Worked example, checked against the tool
A 55-year-old whose periods started at 11-12 (1.1), whose first child was born at 25-29 (1.2), who has one affected first-degree relative (1.7) and one previous biopsy (1.4):
| Run | Combined multiplier | 5-year estimate | Lifetime figure |
|---|---|---|---|
| Worked example above | 1.1 × 1.2 × 1.7 × 1.4 = 3.1416 | 5.72% | 33.32% |
| Every factor neutral | 1.0 | 1.82% | 11.84% |
| Lowest combination | 0.72 | 1.31% | 8.65% |
| Highest combination | 7.956 | 14.48% | 66.24% |
Note the lowest row: the lifetime figure is 8.65%, not five times the 5-year value, because the lifetime figure combines the same age-band averages across each remaining 5-year band to about age 90. It is an approximation, not a clinical lifetime figure. For contrast, our breast cancer risk calculator follows the Gail model approach used by the National Cancer Institute, which fits the same family of factors against recorded incidence rates and does use your age.
How this differs from the real IBIS (Tyrer-Cuzick) model
The genuine IBIS model, published by Tyrer, Duffy and Cuzick in 2004 and maintained as licensed clinical software, is a different instrument. It estimates 10-year and lifetime (to age 85) risk, plus the probability of carrying a BRCA1 or BRCA2 mutation, from a full pedigree and personal profile. Cancer Research Horizons, which licenses the IBIS software, lists inputs this page never asks for: height and BMI, menopause age and status, hormone replacement therapy use, benign breast disease including atypical hyperplasia and lobular carcinoma in situ, breast density, genetic results, and second-degree family history with ages at diagnosis.
Need the real IBIS model? Use the official licensed IBIS tool (Ikonopedia, IBIS v8) or the IBIS Risk Evaluator from EMS Trials / Queen Mary University of London, ideally with a clinician who can enter your full pedigree and interpret the result. This page does not run that model.
| Feature | This estimator | Clinical IBIS / Tyrer-Cuzick |
|---|---|---|
| Risk horizons | 5-year, plus lifetime as 5 × the 5-year figure | 10-year and lifetime to age 85, year by year |
| Effect of your age | None (presence check only) | Central: risk is computed from your current age forward |
| Family history | Count of first-degree relatives only | Full pedigree, both sides, with ages at diagnosis, ovarian cancer and bilateral disease |
| Biopsy detail | Count only | Findings matter: atypical hyperplasia and LCIS carry separate weight |
| Other inputs | None | BMI, menopause, HRT, breast density, BRCA and other gene results |
| Validation | None published | Repeatedly validated in cohort studies, including long-term follow-up with mammographic density |
Clinicians also place validated results into action bands. The NICE familial breast cancer guideline describes lifetime risk under 17% as near population risk, 17% to under 30% as moderate, and 30% or more as high, with different surveillance at each level. Do not map this page’s lifetime figure onto those bands: the bands were built for validated model outputs, and this tool’s lifetime number is a rounded multiple, not a modelled curve. If your family history is strong, the CDC’s early-onset risk factor list is a good checklist for deciding whether to raise genetic counselling with your doctor.
What competing calculators miss
Most pages ranking for this keyword fall into two camps, and both leave something out. Clinical centre pages describe the genuine Tyrer-Cuzick model accurately but make you travel to a licensed tool or a clinic to get a number. Generic “IBIS risk” pages do the opposite: they print a percentage with no formula, no weights and no warning that the arithmetic is a toy version. One widely copied version of this page’s own text even promised risk categories (Low, Moderate, High), lifestyle inputs like smoking and exercise, and a gender field that the actual tool has never contained.
This page takes the third route: the weights are printed in full, the two behaviours (age sets the baseline, lifetime combines age-band averages to about age 90) are stated where you can test them yourself, and the gap between this estimator and the clinical model is laid out input by input. If you have already been diagnosed, risk prediction is the wrong tool entirely; prognosis after diagnosis is what our breast cancer index calculator covers. And if you want population context for any lifetime percentage, the average life expectancy calculator shows the horizon those lifetime figures run over.
Key takeaways
- This is a five-factor educational estimator with an age-specific average baseline, not the clinical IBIS software.
- Your age sets the baseline: try changing only the age and watch both figures move.
- Lifetime risk here combines the age-band averages to about age 90; it is an approximation, nothing more.
- For decisions about screening, prevention medication or genetic testing, use a validated model (clinical IBIS or the NCI tool) with a clinician.
Frequently asked questions
No. The clinical IBIS model is licensed software that uses your age, BMI, menopause and hormone therapy history, biopsy findings, breast density, genetic results and a full family pedigree to estimate 10-year and lifetime risk. This page is a simplified educational estimator that multiplies five factor weights against an age-specific average baseline. Use it to understand how the factors combine, and use a clinical assessment for decisions.
The five weights for menarche age, first-birth age, affected first-degree relatives, previous biopsies and atypical hyperplasia are multiplied together, then multiplied by the published average 5-year risk for your nearest 5-year age band. For example, at age 55, weights of 1.1, 1.2, 1.7 and 1.4 give a combined multiplier of 3.1416 and a 5-year estimate of 5.72% against a 1.82% average.
Yes. Age sets the baseline from the published average-risk table: 0.58% at 35, rising to 2.35% at 70 and easing after, so changing only your age changes both the 5-year and the approximate lifetime figures. In the clinical Tyrer-Cuzick model and in the Gail model, your current age is likewise one of the main drivers of the estimate.
It combines the same published age-band averages across each remaining 5-year band to about age 90, treating each band as a separate period, so it is an approximation, not a modelled lifetime curve. Treat it as a rough figure rather than a prediction to a specific age; it does not reflect competing mortality.
Height and weight (BMI), age at menopause and menopausal status, hormone replacement therapy use and duration, what previous biopsies found (including atypical hyperplasia and lobular carcinoma in situ), mammographic breast density, BRCA1 and BRCA2 and other genetic results, and second-degree relatives with their ages at diagnosis, including ovarian cancer in the family.
Do not act on this number alone. Book a proper risk assessment: a clinician can run a validated model, check your family history in detail and discuss screening intervals, genetic counselling or risk-reducing options if your validated risk is genuinely elevated. A high result here is a prompt for that conversation, not a finding.
No. It produces a statistical estimate from five self-reported factors and examines nothing. A lump, skin change, nipple discharge or any other symptom needs clinical examination and imaging regardless of what any risk calculator says.
Adults roughly 35 to 85 who want a quick, transparent sense of how five classic risk factors combine, for example before a screening appointment. It is not designed for men, for people with a known BRCA mutation, or for anyone who has already had breast cancer; those situations need specialist models and advice.
Add This Calculator to Your Website
Embed this calculator on your own site with the code below. Pick a size to preview it live, then copy the code.
Powered by Calculator Zilo
References
- Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Statistics in Medicine, 2004. Model summary and licensing: Cancer Research Horizons. IBIS software incorporating the Tyrer Cuzick model. Accessed October 22, 2026.
- National Cancer Institute. About the Calculator: The Breast Cancer Risk Assessment Tool (Gail model). Accessed October 22, 2026.
- National Cancer Institute. Breast Cancer Causes and Risk Factors. Accessed October 22, 2026.
- U.S. Preventive Services Task Force. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement, JAMA 2019. PubMed record 31429903. Accessed October 22, 2026.
- Brentnall AR, Cuzick J, et al. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density. JAMA Oncology, 2018. Accessed October 22, 2026.
- Louro J, et al. A systematic review and quality assessment of individualised breast cancer risk prediction models. British Journal of Cancer, via PubMed Central. Accessed October 22, 2026.
- Lee A, et al. Breast cancer risk-assessment models. Breast Cancer Research, via PubMed Central. Accessed October 22, 2026.
- National Institute for Health and Care Excellence. Familial breast cancer guideline CG164: How breast cancer risk is described. Accessed October 22, 2026.
- Centers for Disease Control and Prevention. Risk Factors for Early Breast Cancer (Bring Your Brave). Accessed October 22, 2026.
- Centers for Disease Control and Prevention. Hereditary Breast and Ovarian Cancer Algorithm, My Family Health Portrait: Cancer. Accessed October 22, 2026.
- MD Anderson Cancer Center. Breast cancer risk assessments: What to know. Accessed October 22, 2026.
- BreastCancer.org. Breast Cancer Risk Calculators (BCRAT, BCSC and Tyrer-Cuzick compared). Accessed October 22, 2026.